Utility of next generation sequencing for differentiating malignant PEComa from metastatic melanoma

Elizabeth Paver; Karina Aivazian; Fiona Maclean; Georgina V. Long; Andrew J. Spillane; James S. Wilmott; Richard A. Scolyer

doi:10.1016/j.pathol.2022.08.011

Utility of next generation sequencing for differentiating malignant PEComa from metastatic melanoma

Elizabeth Paver, Karina Aivazian, Fiona Maclean, Georgina V. Long, Andrew J. Spillane, James S. Wilmott, Richard A. Scolyer^*

^*Corresponding author for this work

Macquarie Medical School

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	555-560
Number of pages	6
Journal	Pathology
Volume	55
Issue number	4
DOIs	https://doi.org/10.1016/j.pathol.2022.08.011
Publication status	Published - Jun 2023

Access to Document

10.1016/j.pathol.2022.08.011

Cite this

@article{b2d108fb960d4d76841ca6432751034c,

title = "Utility of next generation sequencing for differentiating malignant PEComa from metastatic melanoma",

author = "Elizabeth Paver and Karina Aivazian and Fiona Maclean and Long, {Georgina V.} and Spillane, {Andrew J.} and Wilmott, {James S.} and Scolyer, {Richard A.}",

year = "2023",

month = jun,

doi = "10.1016/j.pathol.2022.08.011",

language = "English",

volume = "55",

pages = "555--560",

journal = "Pathology",

issn = "0031-3025",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - Utility of next generation sequencing for differentiating malignant PEComa from metastatic melanoma

AU - Paver, Elizabeth

AU - Aivazian, Karina

AU - Maclean, Fiona

AU - Long, Georgina V.

AU - Spillane, Andrew J.

AU - Wilmott, James S.

AU - Scolyer, Richard A.

PY - 2023/6

Y1 - 2023/6

UR - http://www.scopus.com/inward/record.url?scp=85156272961&partnerID=8YFLogxK

U2 - 10.1016/j.pathol.2022.08.011

DO - 10.1016/j.pathol.2022.08.011

M3 - Letter

C2 - 36400594

AN - SCOPUS:85156272961

SN - 0031-3025

VL - 55

SP - 555

EP - 560

JO - Pathology

JF - Pathology

IS - 4

ER -

Utility of next generation sequencing for differentiating malignant PEComa from metastatic melanoma

Access to Document

Other files and links

Cite this